Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development
06:00 EDT 6 Sep 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Aduro BioTech, Inc. announces the award of a Congressionally Directed
Medical Research Programs (CDMRP) grant from the Department of Defense.
The grant of $867,846 will be used to complete the preclinical
development of a novel ...
Other Sources for this Article
Aduro BioTech, Inc.
Steven Bodovitz, Ph.D., +510-809-4813
sbodovitz@adurobiotech.com
More From BioPortfolio on "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
